TTRX
Turn Therapeutics Inc. Common Stock
NASDAQ: TTRX · HEALTHCARE · BIOTECHNOLOGY
$3.69
+3.81% today
Updated 2026-04-30
Market cap
$107.24M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$3 – $10
Volume
0.0M
Turn Therapeutics Inc. Common Stock (TTRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 3
Last 3 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-9.1%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $0.01 | — | $3.22 | $3.12 | -3.3% |
| 2025-11-13 | $-0.07 | — | $4.40 | $4.00 | -9.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $0.01 | — | — | — |
| 2025-09-30 | $0.00 | $-0.07 | — | — | — |
| 2025-06-30 | $0.00 | $-0.05 | — | — | — |
Frequently asked questions
Has Turn Therapeutics Inc. Common Stock beaten earnings estimates?
Turn Therapeutics Inc. Common Stock has beaten Wall Street EPS estimates in 0 of its last 3 quarterly reports.
How does TTRX stock react to earnings?
TTRX stock has moved an average of -6.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.